RYTM- Rhythm Pharmaceuticals, Inc.
Rhythm Pharmaceuticals, Inc. (RYTM) has 12 insiders with recent SEC Form 4 filings, including 0 buys and 18 sells. RYTM is classified in the Biotechnology industry within the Health Care sector.
Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 270.5K | $29.95M | - | |
| CFO | 110.5K | $12.23M | - | |
| Other | 20.8K | $2.30M | - | |
| Other | 18.8K | $2.08M | - | |
| Dir | 6.8K | $753.7K | - |
Activity
Buys and sells only
Transactions
10 filings · page 2
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 13, 2025 | Smith Hunter C | Chief Financial Officer | Sale+OE | 28,088 | $96.29 | $2,704,623.77 | -10.7% | +2.0% | - | |
| Aug 12, 2025 | German Christopher Paul | Corporate Controller &CAO | Sale+OE | 1,500 | $95.00 | $142,500.00 | -61.9% | +1.2% | - | |
| Aug 11, 2025 | Shulman Joseph | Chief Technical Officer | Sale+OE | 3,984 | $90.08 | $358,891.47 | -31.9% | +3.5% | - | |
| Jul 29, 2025 | Cramer Pamela J. | Chief Human Resources Officer | Sale+OE | 1,520 | $85.93 | $130,613.60 | -6.8% | +30.3% | +24.4% | |
| Jul 9, 2025 | Smith Hunter C | Chief Financial Officer | Sale+OE | 42,120 | $80.48 | $3,389,756.13 | -9.5% | +12.2% | +29.8% | |
| Jul 9, 2025 | Shulman Joseph | Chief Technical Officer | Sale+OE | 7,969 | $77.78 | $619,850.56 | -27.5% | +12.2% | +29.8% | |
| Jul 9, 2025 | German Christopher Paul | Corporate Controller &CAO | Sale+OE | 3,817 | $80.75 | $308,217.25 | -50.8% | +12.2% | +29.8% | |
| Jul 9, 2025 | Cramer Pamela J. | Chief Human Resources Officer | Sale+OE | 15,572 | $77.13 | $1,201,062.21 | -17.7% | +12.2% | +29.8% | |
| Jul 2, 2025 | Garfield Alastair | Chief Scientific Officer | Sale+OE | 1,319 | $64.81 | $85,483.13 | -17.4% | +50.9% | +70.6% | |
| Jun 10, 2025 | German Christopher Paul | Corporate Controller &CAO | Sale+OE | 2,069 | $67.19 | $139,016.11 | -52.3% | +48.1% | +27.2% |